Factor Therapeutics Limited announced the appointment of Dr. Rosalind Wilson to the position of Chief Executive Officer ("CEO"). Dr. Wilson will commence as CEO on the June 19, 2017 and Mr. Johnson will resume the position of Chief Operating Officer (COO) at that time. Dr. Wilson's career has spanned a variety of senior leadership and advisory roles from small innovation-led businesses to global biopharma, including Business Manager at NucleusX and strategy/portfolio management roles at F.Hoffman-LaRoche (Roche Australia, UK and Switzerland). Prior to joining Factor, Dr. Wilson was Executive Officer at the Lung Foundation Australia.